Sponsor of Gastro Update 2023, two-day scientific and educational events for gastroenterology professionals

Patient Education Day in the city of Mainz, Germany, the company’s headquarters

Germany-based specialist in molecular diagnostics to support local colorectal cancer communities

BERKELEY, Calif. and MAINZ, Germany, March 08, 2023 (GLOBE NEWSWIRE) — Mainz Biomed NV MYNZ (“Mainz Biomed” or the “Company”), a molecular genetics diagnostics company specializing in the early detection of cancer, is launching a series of events to raise awareness among physicians and healthcare professionals of the importance of early detection of colorectal cancer (CRC), but also with Patients, their families, caregivers and the general public in Germany.

“With around 73,000 new cases per year in Germany alone, CRC is one of the most common types of cancer. It is also the second deadliest type of cancer nationwide. However, the 5-year survival rate is over 90% if they are detected in early stages,” said Darin Leigh, Mainz Biomed’s Chief Commercial Officer. “As a company based in Mainz, Germany, it is important to us to continue the efforts of patient organizations and the local cancer community during CRC Awareness Month We organized awareness events to highlight the relevance of early detection to improved treatment options and better patient outcomes Regular screening with an easy-to-use, non-invasive, home CRC test kit can save lives! “

Support of the Gastro Update 2023 in Mainz and Berlin as a sponsor
Mainz Biomed is sponsoring this year’s Gastro Update, a series of two two-day hands-on training events for healthcare professionals led by renowned German gastroenterologists. The company will have a stand throughout the scientific event in Mainz and Berlin, Germany, and will take part in the subsequent stakeholder dinner.

Gastro update 2023
#1 Friday and Saturday 10-11 March 2023
Rheingold Hall; Mainz, Germany

#2 Friday and Saturday,…